Journal article
Medication-related osteonecrosis of the jaw: Analysing the range of implicated drugs from the Australian database of adverse event notifications
Leanne Teoh, Geraldine Moses, Amanda P Nguyen, Michael J McCullough
British Journal of Clinical Pharmacology | WILEY | Published : 2020
DOI: 10.1111/bcp.14681
Abstract
AIMS: Medication-related osteonecrosis of the jaw (MRONJ) is an uncommon but potentially debilitating condition, characterised by nonhealing jawbone, with or without mucosal exposure, in the presence of certain drugs. Those already strongly associated with MRONJ include antiresorptives denosumab and bisphosphonates; however, a growing range of other non-antiresorptive drugs is implicated. The aim of this study was to analyse all case reports of MRONJ submitted to the publicly available Database of Adverse Event Notification from the Therapeutic Goods Administration in Australia. METHODS: The Therapeutic Goods Administration was contacted on 6 January 2020 and asked for all reports containing..
View full abstractGrants
Awarded by Australian Government Research Training Program Scholarship
Funding Acknowledgements
Australian Government Research Training Program Scholarship, Grant/Award Number: 241616